A de novo designed possible 5-lipoxygenase inhibitor: α-acetoxy-W-[1-(1-tricyclo[3.3.1.1 3,7]dec-1-yl)ethyl]benzeneacetamide

Acta Crystallographica Section C: Crystal Structure Communications

Volumn 52, Issue 3, 1996, Pages 677-679

  Hamodrakas, Stavros J ^a   Perrakis, Anastassis ^b,c   Antoniadou Vyzas, Ekaterini ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS; CRYSTAL ATOMIC STRUCTURE; CRYSTALLOGRAPHY; ENZYME INHIBITION; ENZYMES; MACROMOLECULES; METABOLISM; SYNTHESIS (CHEMICAL);

ANTI INFLAMMATORY AGENT; ARACHIDONIC ACID; ENZYME INHIBITORS; LEUKOTRIENES;

AROMATIC COMPOUNDS;

EID: 0030106101     PISSN: 01082701     EISSN: None     Source Type: Journal    
DOI: 10.1107/S0108270195013084     Document Type: Article

References (7)

1. Gasland, L. G. & Salmon, J. A. (1991). Drugs Future, 16, 547.
2. Grochowski, J., Serda, P., Wilson, K. S. & Dauter, Z. (1994). J. Appl. Cryst. 27, 722-726.
3. Johnson, C. K. (1976). ORTEPII. Report ORNL-5138. Oak Ridge National Laboratory, Tennessee, USA.
4. Musser, J. H. & Kreff, A. F. (1992). J. Med. Chem. 35, 2501-2524.
5. Otwinowski, Z. (1993). DENZO. An Oscillation Data Processing Program for Macromolecular Crystallography. Yale University, New Haven, USA.
6. Sheldrick, G. M. (1985). SHELXS86. Program for the Solution of Crystal Structures. University of Göttingen, Germany.
7. Sheldrick, G. M. (1993). SHELXL93. Program for the Refinement of Crystal Structures. University of Göttingen, Germany.